Introduction
============

Datasets for differentially expressed proteins in cancer are often interpreted from a mechanistic perspective that emphasizes molecular interactions. Alternative approaches exemplified by recent models that use information theory demonstrate the possibility of interpreting proteomic expression data in a high-level conceptual framework ([@ref-83], [@ref-83]). These approaches may combine concepts from dynamical systems theory and thermodynamics, such as the possible association of "attractor states" in landscape models with low-energy states of a system ([@ref-30], [@ref-30]; [@ref-22], [@ref-22]). Despite these advances, energetic functions for differential protein expression have rarely been formulated in terms of physicochemical variables that reflect the conditions of tumor microenvironments. The coupling of recent proteomic data with thermodynamic models using chemical components provides new perspectives on microenvironmental conditions that are conducive to carcinogenesis or healthy growth.

The purpose of the present study is to explore human proteomic and microbial community data for colorectal cancer within a chemical and thermodynamic framework using variables that represent oxidation and hydration state. This is carried out first by comparing chemical compositions of up- and down-expressed proteins along the normal tissue--adenoma--carcinoma progression. Then, a thermodynamic model is used to quantify the overall energetics of the proteomic transformations in terms of chemical potential variables. This approach reveals not only common patterns of chemical changes among many proteomic datasets, but also the possibility that proteomic transformations may be shaped by energetic constraints associated with the changing tumor microenvironment.

Recent years have seen the appearance of many proteomic datasets for colorectal cancer (CRC), a very common and extensively studied type of human cancer. Genomic instability is often considered to be the primary driver of cancer progression ([@ref-55], [@ref-55]). However, not only genetic transformations, but also microenvironmental dynamics can influence cancer progression ([@ref-87], [@ref-87]). Many reactions in the microenvironment, such as those involving hormones or cell--cell signaling interactions, operate on fast timescales, but local hypoxia in tumors and other microenvironmental changes can develop and persist over longer timescales. The long timescales of carcinogenesis may be sufficient for cells to adapt their proteomes to the differential energetic costs of biomolecular synthesis imposed by changing chemical conditions of the microenvironment.

One of the characteristic features of tumors is varying degrees of hypoxia ([@ref-46], [@ref-46]). Hypoxic conditions promote activation of hypoxia-inducible genes by the HIF-1 transcription factor and intensify the mitochondrial generation of reactive oxygen species (ROS) ([@ref-76], [@ref-76]), leading to oxidative stress ([@ref-46], [@ref-46]; [@ref-88], [@ref-88]). It is important to note that there is significant intra-tumor and inter-tumor heterogeneity of oxygenation levels ([@ref-46], [@ref-46]; [@ref-23], [@ref-23]). Cancer cells can also exhibit changes in oxidation--reduction (redox) state; for example, redox potential (Eh) monitored *in vivo* in a fibrosarcoma cell line is altered compared to normal fibroblasts ([@ref-47], [@ref-47]).

The hydration states of cancer cells and tissues may also vary considerably from their healthy counterparts. Microwave detection of differences in dielectric constant resulting from greater water content in malignant tissue is being developed for medical imaging of breast cancer ([@ref-35], [@ref-35]). IR and Raman spectroscopic techniques also reveal a greater hydration state of cancerous breast tissue, resulting from interaction of water molecules with hydrophilic cellular structures of cancer cells but negligible association with the triglycerides and other hydrophobic molecules that are more common in normal tissue ([@ref-1], [@ref-1]).

Increased hydration levels may be associated with a higher abundance of hyaluronan found in the extracellular matrix (ECM) of migrating and metastatic cells ([@ref-96], [@ref-96]), while a higher subcellular hydration state may alter cell function by acting as a signal for protein synthesis and cell proliferation ([@ref-40], [@ref-40]). It has also been hypothesized that the increased hydration of cancer cells underlies a reversion to a more embryonic state ([@ref-71], [@ref-71]). Based on all of these considerations, compositional and thermodynamic variables related to redox and hydration state have been selected as the primary descriptive variables in this study.

As noted by others, it seems paradoxical that hypoxia, i.e., low oxygen partial pressure, could be a driving force for the generation of oxidative molecules. Possibly, the mitochondrial generation of ROS is a cellular mechanism for oxygen sensing ([@ref-37], [@ref-37]). Whether through hypoxia-induced oxidative stress or other mechanisms, proteins in cancer have been found to have a variety of oxidative post-translational modifications (PTM), including carbonylation and oxidation of cysteine residues ([@ref-109], [@ref-109]; [@ref-107], [@ref-107]). Although proteome-level assessments of oxidative PTM are gaining traction ([@ref-107], [@ref-107]), existing large-scale proteomic datasets may carry other signals of oxidation state. One possible "syn-translational" indicator of oxidation state, inherent in the amino acid sequences of proteins, is the average oxidation state of carbon, which is introduced below. At the outset, it is not clear whether such a metric of oxidation state would more closely track hypoxia (i.e., relatively reducing conditions) that may arise in tumors, or a more oxidizing potential connected with ROS and oxidative PTM.

Density functional theory and other computational methods that yield electron density maps of proteins with known structure can be used to compute the partial charges, or oxidation states, of all the atoms. Spectroscopic methods can also be used to determine oxidation states of atoms in molecules ([@ref-36], [@ref-36]). These theoretical and empirical approaches offer the greatest precision in an oxidation state calculation, but it is difficult to apply them to the hundreds of proteins, many with undetermined three-dimensional structures, found to have significantly altered expression in proteomic experiments. Other methods for estimating the oxidation states of atoms in molecules may be needed to assess the overall direction of electron flow in a proteomic transformation.

Some textbooks of organic chemistry present the concept of formal oxidation states, in which the electron pair in a covalent bond is formally assigned to the more electronegative of the two atoms (e.g., [@ref-44], [@ref-44], ch. 18). This rule is consistent with the current IUPAC recommendations for calculating oxidation state of atoms in molecules, but generalizes the IUPAC definitions such that the oxidation states of different carbon atoms in organic molecules can be distinguished (e.g., [@ref-65], [@ref-65]; [@ref-36], [@ref-36]). In the primary structure of a protein, where no metal atoms are present and heteroatoms are bonded only to carbon and/or hydrogen, the average oxidation state of carbon (*Z*~C~) can be calculated as an elemental ratio, which is easily obtained from the amino acid composition ([@ref-27], [@ref-27]). In a protein with the chemical formula C~*c*~H~*h*~N~*n*~O~*o*~S~*s*~, the average oxidation state of carbon (*Z*~C~) is $$\documentclass[12pt]{minimal}
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}{}\begin{eqnarray*}{Z}_{\mathrm{C}}= \frac{3n+2o+2s-h}{c} .\end{eqnarray*}\end{document}$$This equation is equivalent to others, also written in terms of numbers of the elements C, H, N, O and S, used for the average oxidation state of carbon in algal biomass ([@ref-12], [@ref-12]), in humic and fulvic acids ([@ref-31], [@ref-31]), and for the nominal oxidation state of carbon in dissolved organic matter ([@ref-82], [@ref-82]).

Comparing the average carbon oxidation states in organic molecules is useful for quantifying the reactions of complex mixtures of organic matter in aerosols ([@ref-60], [@ref-60]), the growth of biomass ([@ref-39], [@ref-39]) and the production of biofuels ([@ref-13], [@ref-13]; [@ref-12], [@ref-12]). There is a considerable range of the average oxidation state of carbon in different amino acids ([@ref-69], [@ref-69]; [@ref-5], [@ref-5]), with consequences for the energetics of synthesis depending on environmental conditions ([@ref-6], [@ref-6]). Similarly, the nominal oxidation state of carbon can be used as a proxy for the standard Gibbs energies of oxidation reactions of various organic and biochemical molecules ([@ref-8], [@ref-8]). The oxidation state concept can be used as a bookkeeping tool to understand electron flow in metabolic pathways, yet may receive limited coverage in biochemistry courses ([@ref-38], [@ref-38]). There has been scant attention in the literature to the differences in carbon oxidation state among proteins or other biomacromolecules. Nevertheless, the ease of computation makes *Z*~C~ a useful metric for rapidly ascertaining the direction and magnitude of electron flow associated with proteomic transformations during disease progression.

Comparisons of oxidation states of carbon can be used to rank the energetics of reactions of organic molecules in particular systems ([@ref-5], [@ref-5]). However, quantifying the energetics and mass-balance requirements of chemical transformations requires a more complete thermodynamic model. Thermodynamic models that are based on chemical components (or basis species), i.e., a minimum number of independent chemical formula units that can be combined to form any chemical species in the system, have an established position in geochemistry ([@ref-7], [@ref-7]; [@ref-10], [@ref-10]). The implications of choosing different sets of components, called the "basis" ([@ref-10], [@ref-10]), have received relatively little discussion in biochemistry, although [@ref-3] ([@ref-3]) in a similar context highlighted the observation made by [@ref-16] ([@ref-16]) that "\[t\]he choice of variables in terms of which a given system is formulated, while seemingly an innocuous step, is often the most crucial step in the solution". Models built with different choices of components nevertheless yield equivalent results when consistently parameterized ([@ref-73], [@ref-73]; [@ref-81], [@ref-81]). Accordingly, components are a type of chemical accounting for reactions in a system ([@ref-73], [@ref-73]), and do not necessarily constitute mechanistic models for those reactions.

The structure and dynamics of the hydration shells of proteins have important biological consequences ([@ref-63], [@ref-63]) and can be investigated in molecular simulation studies ([@ref-102], [@ref-102]). Statistical thermodynamics can be used to assess the effects of preferential hydration of protein surfaces on unfolding or other conformational changes ([@ref-62], [@ref-62]). However, there is also a role for H~2~O as a chemical component in stoichiometric reactions representing the mass-balance requirements for formation of proteins with different amino acid sequences.

For example, a system of proteins composed of C, H, N, O and S can be described using the (non-innocuous) components CO~2~, NH~3~, H~2~S, O~2~ and H~2~O. Accordingly, stoichiometric reactions representing the formation of certain proteins at the expense of others during a proteomic transformation generally have non-zero coefficients on O~2~, H~2~O and the other components. These stoichiometric reactions can be written without specific knowledge of electron density in proteins or hydration by molecular H~2~O.

It bears repeating that reactions written using chemical components are not mechanistic representations. Instead, these reactions are specific statements of the requirement for mass balance that can be used to build thermodynamic models of chemically reacting systems ([@ref-43], [@ref-43]). Flux-balance models of metabolic networks integrate stoichiometric constraints (e.g., [@ref-45], [@ref-45]), but stoichiometric descriptions of proteomic transformations are less common, perhaps because of a greater degree of abstraction away from elementary reactions. Nevertheless, the differentially down- and up-expressed proteins in a proteomic dataset furnish a quantitative description of a proteomic transformation and can be viewed as the initial and final states of a chemically reacting system, which is then amenable to thermodynamic modeling.

The chemical potentials of components can be used to describe the internal state of a system and, for an open system, its relation to the environment. Oxygen fugacity is a variable that is related to the chemical potential of O~2~; it does not necessarily reflect the concentration of O~2~, but instead indicates the distribution of species with different oxidation states ([@ref-2], [@ref-2]). Theoretical calculation of the energetics of reactions as a function of oxygen fugacity provides a useful reference for the relative stabilities of organic molecules in different environments ([@ref-43], [@ref-43]; [@ref-5], [@ref-5]). However, in a cellular context a multidimensional approach may be required to quantify possible microenvironmental influences on the potentials for biochemical transformations. Likely variables include not only oxidation state but also water activity. Scenarios for early metabolic and cellular evolution ([@ref-78], [@ref-78]; [@ref-85], [@ref-85]; [@ref-21], [@ref-21]) lend additional support to the choice of water activity as a primary variable of interest.

A thermodynamic model that is formulated in terms of carefully selected basis species affords a convenient description of a system. As described in the Methods, a basis is selected that reduces the empirical correlation between average oxidation state of carbon and the coefficient on H~2~O in formation reactions of proteins from basis species. The first part of the Results shows compositional comparisons for human and microbial proteins ('Compositional comparisons of human proteins'--'Compositional comparisons of microbial proteins') in 35 datasets from 20 different studies. Many of the comparisons reveal higher *Z*~C~ or higher water demand for the formation of proteins up-expressed in cancer compared to normal tissue. Contrary to the trends observed for human proteins, the average protein compositions of bacteria enriched in cancer tend to have lower *Z*~C~.

To better understand the biochemical context of these differences, calculations reported in the second part of the Results use chemical affinity (negative Gibbs energy of reaction) to predict the most stable molecules as a function of oxygen fugacity and water activity ('Thermodynamic descriptions: background'--'Relative stability fields for human proteins'). Theoretical calculations of the relative stabilities of groups of up- and down-expressed proteins build on the compositional descriptions as a step toward quantifying the microenvironmental conditions that may promote or impede the proteomic alterations associated with the progression of cancer.

Methods
=======

Data sources
------------

This section describes the data sources and additional data processing steps applied in this study. An attempt was made to locate all currently available proteomic studies for clinical tissue on CRC including, among others, those listed in the "Tissue" and "Tissue subproteomes" sections of the review paper by [@ref-24] ([@ref-24]) and in Supporting Table 3 ("Clinical Samples") of the review paper by [@ref-67] ([@ref-67]). To make the comparisons more robust, only datasets with at least 30 proteins in each of the up- and down-regulated groups were considered; however, all datasets from a given study were included if at least one of the datasets met this criterion. The reference keys for the selected studies shown below and in [Table 1](#table-1){ref-type="table"} are derived from the names of the authors and year of publication.
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###### Summary of compositional comparisons for human proteins.

Mean differences (MD), percent values of common language effect size (ES), and *p*-values are shown for comparisons between groups of proteins reported to have higher abundance in normal (*n*~1~) or cancer (*n*~2~) tissue (or less advanced or more advanced cancer stages, respectively). The textual descriptions are written such that the ordering around the slash ("/") corresponds to *n*~2~/*n*~1~. References and specific abbreviations used in the descriptions are given in 'Data sources'.
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  `WTK+08` (T/N)                         57       70       0.018           55                                                            3e--01       0.006          52       7e--01
  `AKP+10` (CRC nuclear matrix C/A)      101      28       −0.012          47                                                            7e--01       −0.009         48       8e--01
  `AKP+10` (CIN nuclear matrix C/A)      87       81       **−0.031**      **40**                                                        **3e--02**   0.006          48       7e--01
  `AKP+10` (MIN nuclear matrix C/A)      157      76       −0.002          52                                                            7e--01       −0.013         45       3e--01
  `JKMF10` (serum biomarkers up/down)    43       56       −0.007          46                                                            5e--01       **0.056**      **67**   **4e--03**
  `XZC+10` (stage I/normal)              48       166      0.009           52                                                            7e--01       0.026          56       2e--01
  `XZC+10` (stage II/normal)             77       321      **0.022**       **60**                                                        **6e--03**   0.018          54       3e--01
  `ZYS+10` (microdissected T/N)          60       57       0.019           58                                                            1e--01       0.022          58       1e--01
  `BPV+11` (adenoma/normal)              71       92       **−0.023**      **40**                                                        **4e--02**   0.004          49       8e--01
  `BPV+11` (stage I/normal)              109      72       -0.007          47                                                            5e--01       0.005          50       9e--01
  `BPV+11` (stage II/normal)             164      140      **0.031**       **62**                                                        **3e--04**   0.006          51       7e--01
  `BPV+11` (stage III/normal)            63       131      **0.025**       **62**                                                        **9e--03**   −0.005         47       5e--01
  `BPV+11` (stage IV/normal)             42       26       −0.010          44                                                            4e--01       0.005          52       8e--01
  `JCF+11` (T/N)                         72       45       **0.032**       **63**                                                        **2e--02**   −0.003         49       8e--01
  `MRK+11` (adenoma/normal)              335      288      0.011           54                                                            1e--01       **0.058**      **68**   **2e--15**
  `MRK+11` (adenocarcinoma/adenoma)      373      257      **0.034**       **65**                                                        **1e--10**   −0.009         47       1e--01
  `MRK+11` (adenocarcinoma/normal)       351      232      **0.034**       **63**                                                        **4e--08**   **0.035**      **61**   **8e--06**
  `KKL+12` (poor/good prognosis)         75       61       **0.026**       **64**                                                        **5e--03**   −0.002         48       8e--01
  `KYK+12` (MSS-type T/N)                73       175      **0.024**       **61**                                                        **9e--03**   0.023          56       1e--01
  `WOD+12` (T/N)                         79       677      0.016           54                                                            2e--01       [0.027]{.ul}   58       **2e--02**
  `YLZ+12` (conditioned media T/N)       55       68       **0.024**       **61**                                                        **4e--02**   0.009          54       5e--01
  `MCZ+13` (stromal T/N)                 33       37       **0.047**       **74**                                                        **5e--04**   −0.034         42       2e--01
  `KWA+14` (chromatin-binding C/A)       51       55       **−0.039**      **29**                                                        **2e--04**   −0.010         48       7e--01
  `UNS+14` (epithelial adenoma/normal)   58       65       0.001           49                                                            8e--01       **0.032**      **61**   **4e--02**
  `WKP+14` (tissue secretome T/N)        44       210      0.006           53                                                            6e--01       **0.057**      **68**   **1e--04**
  `STK+15` (membrane enriched T/N)       113      66       0.005           52                                                            6e--01       0.025          55       2e--01
  `WDO+15` (adenoma/normal)              1,061    1,254    **0.030**       **64**                                                        **7e--33**   [0.023]{.ul}   58       **7e--11**
  `WDO+15` (carcinoma/adenoma)           772      1,007    [−0.013]{.ul}   42                                                            **2e--08**   −0.003         50       7e--01
  `WDO+15` (carcinoma/normal)            879      1,281    [0.014]{.ul}    57                                                            **9e--08**   [0.024]{.ul}   58       **1e--10**
  `LPL+16` (stromal AD/NC)               123      75       **−0.039**      **32**                                                        **2e--05**   **0.037**      **60**   **2e--02**
  `LPL+16` (stromal CIS/NC)              125      60       −0.007          46                                                            4e--01       −0.001         52       7e--01
  `LPL+16` (stromal ICC/NC)              99       75       0.001           47                                                            6e--01       −0.021         48       7e--01
  `PHL+16` (AD/NC)                       113      86       0.011           54                                                            4e--01       **0.037**      **60**   **2e--02**
  `PHL+16` (CIS/NC)                      169      138      [0.019]{.ul}    59                                                            **5e--03**   0.001          49       7e--01
  `PHL+16` (ICC/NC)                      129      100      0.016           57                                                            6e--02       −0.007         46       3e--01

**Notes.**

AbbreviationsT/Ntumor/normalC/Acarcinoma/adenoma

In comparisons between groups of up- and down-expressed proteins, the convention in this study is to consider proteins with higher expression in normal tissue or less-advanced cancer stages as a "normal" group (group 1), with number of proteins *n*~1~, while proteins with higher expression in cancer or more-advanced cancer stages are categorized as a "cancer" group (group 2), with number of proteins *n*~2~. For example, in the dataset of [@ref-97] ([@ref-97]) comparing normal mucosa and adenoma, the proteins up-expressed in adenoma are assigned to group 2, while in the adenoma---carcinoma dataset of [@ref-57] ([@ref-57]), the proteins with higher expression in adenoma are assigned to group 1 (see [Table 1](#table-1){ref-type="table"}).

Names or IDs of genes or proteins given in the sources were searched in UniProt ([@ref-95], [@ref-95]). The corresponding UniProt IDs are provided in the `*.csv` data files in [Dataset S1](#supp-1){ref-type="supplementary-material"}. Amino acid sequences of human proteins were taken from the UniProt reference proteome (files `UP000005640_9606.fasta.gz` containing canonical, manually reviewed sequences, and `UP000005640_9606_additional.fasta.gz` containing isoforms and unreviewed sequences, dated 2016-04-13, downloaded from <ftp://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/reference_proteomes/Eukaryota/>). Entire sequences were used; i.e., signal peptides and propeptides were not removed when calculating the amino acid compositions. However, amino acid compositions were calculated for particular isoforms, if these were identified in the sources. Files `human.aa.csv` and `human_additional.aa.csv` in [Dataset S1](#supp-1){ref-type="supplementary-material"} contain the amino acid compositions of the proteins calculated from the UniProt reference proteome. In a few cases, amino acid compositions of unreviewed or obsolete sequences in UniProt, not available in the reference proteome, were individually compiled; these are contained in file `human2.aa.csv` in [Dataset S1](#supp-1){ref-type="supplementary-material"}.

Reported gene names were converted to UniProt IDs using the UniProt mapping tool (<http://www.uniprot.org/mapping>), and IPI accession numbers were converted to UniProt IDs using the DAVID conversion tool (<https://david.ncifcrf.gov/content.jsp?file=conversion.html>). For proteins with no automatically generated matches, manual searches in UniProt of the protein descriptions, where available, were performed. Proteins with missing or duplicated identifiers, or those that could not be matched to a UniProt ID, were omitted from the comparisons here. Therefore, the numbers of proteins actually used in the comparisons (listed in [Table 1](#table-1){ref-type="table"}) may be different from the numbers of proteins reported by the authors and summarized below.

`WTK+08`: [@ref-101] ([@ref-101]) used 2-nitrobenzenesulfenyl labeling and MS/MS analysis to identify 128 proteins with differential expression in paired CRC and normal tissue specimens from 12 patients. The list of proteins used in this study was generated by combining the lists of up- and down-regulated proteins from [Table 1](#table-1){ref-type="table"} and Supplementary Data 1 of [@ref-101] ([@ref-101]) with the Swiss-Prot and UniProt accession numbers from their Supplementary Data 2.

`AKP+10`: [@ref-4] ([@ref-4]) used nano-LC-MS/MS to characterize proteins from the nuclear matrix fraction in samples from 2 patients each with adenoma (ADE), chromosomal instability CRC (CIN+) and microsatellite instability CRC (MIN+). Cluster analysis was used to classify proteins with differential expression between ADE and CIN+, MIN+, or in both subtypes of carcinoma (CRC). Here, gene names from Supplementary Tables 5--7 of [@ref-4] ([@ref-4]) were converted to UniProt IDs using the UniProt mapping tool.

`JKMF10`: [@ref-50] ([@ref-50]) compiled a list of candidate serum biomarkers from a meta-analysis of the literature. In the meta-analysis, 99 up- or down-expressed proteins were identified in at least 2 studies. The list of UniProt IDs used in this study was taken from Table 4 of [@ref-50] ([@ref-50]).

`XZC+10`: [@ref-106] ([@ref-106]) used a gel-enhanced LC-MS method to analyze proteins in pooled tissue samples from 13 stage I and 24 stage II CRC patients and pooled normal colonic tissues from the same patients. Here, IPI accession numbers from Supplemental Table 4 of [@ref-106] ([@ref-106]) were converted to UniProt IDs using the DAVID conversion tool.

`ZYS+10`: [@ref-113] ([@ref-113]) used acetylation stable isotope labeling and LTQ-FT MS to analyze proteins in pooled microdissected epithelial samples of tumor and normal mucosa from 20 patients, finding 67 and 70 proteins with increased or decreased expression (ratios ≥2 or ≤0.5). Here, IPI accession numbers from Supplemental Table 4 of [@ref-113] ([@ref-113]) were converted to UniProt IDs using the DAVID conversion tool.

`BPV+11`: [@ref-9] ([@ref-9]) analyzed microdissected cancer and normal tissues from 28 patients (4 adenoma samples and 24 CRC samples at different stages) using iTRAQ labeling and MALDI-TOF/TOF MS to identify 555 proteins with differential expression between adenoma and stage I, II, III, IV CRC. Here, gene names from supplemental Table 9 of [@ref-9] ([@ref-9]) were converted to UniProt IDs using the UniProt mapping tool.

`JCF+11`: [@ref-49] ([@ref-49]) analyzed paired samples from 16 patients using iTRAQ-MS to identify 118 proteins with \>1.3-fold differential expression between CRC tumors and adjacent normal mucosa. The protein list used in this study was taken from Supplementary Table 2 of [@ref-49] ([@ref-49]).

`MRK+11`: [@ref-72] ([@ref-72]) used iTRAQ labeling with LC-MS/MS to identify a total of 1,061 proteins with differential expression (fold change ≥1.5 and false discovery rate ≤0.01) between pooled samples of 4 normal colon (NC), 12 tubular or tubulo-villous adenoma (AD) and 5 adenocarcinoma (AC) tissues. The list of proteins used in this study was taken from Table S8 of [@ref-72] ([@ref-72]).

`KKL+12`: [@ref-54] ([@ref-54]) used difference in-gel electrophoresis (DIGE) and cleavable isotope-coded affinity tag (cICAT) labeling followed by mass spectrometry to identify 175 proteins with more than 2-fold abundance ratios between microdissected and pooled tumor tissues from stage-IV CRC patients with good outcomes (survived more than five years; 3 patients) and poor outcomes (died within 25 months; 3 patients). The protein list used in this study was made by filtering the cICAT data from Supplementary Table 5 of [@ref-54] ([@ref-54]) with an abundance ratio cutoff of \>2 or \<0.5, giving 147 proteins. IPI accession numbers were converted to UniProt IDs using the DAVID conversion tool.

`KYK+12`: [@ref-52] ([@ref-52]) used mTRAQ and cICAT analysis of pooled microsatellite stable (MSS-type) CRC tissues and pooled matched normal tissues from 3 patients to identify 1,009 and 478 proteins in cancer tissue with increased or decreased expression by higher than 2-fold, respectively. Here, the list of proteins from Supplementary Table 4 of [@ref-52] ([@ref-52]) was filtered to include proteins with expression ratio \>2 or \<0.5 in both mTRAQ and cICAT analyses, leaving 175 up-expressed and 248 down-expressed proteins in CRC. Gene names were converted to UniProt IDs using the UniProt mapping tool.

`WOD+12`: [@ref-105] ([@ref-105]) used LC-MS/MS to analyze proteins in microdissected samples of formalin-fixed paraffin-embedded (FFPE) tissue from 8 patients; at *P* \< 0.01, 762 proteins had differential expression between normal mucosa and primary tumors. The list of proteins used in this study was taken from Supplementary Table 4 of [@ref-105] ([@ref-105]).

`YLZ+12`: [@ref-108] ([@ref-108]) analyzed the conditioned media of paired stage I or IIA CRC and normal tissues from 9 patients using lectin affinity capture for glycoprotein (secreted protein) enrichment by nano LC-MS/MS to identify 68 up-regulated and 55 down-regulated differentially expressed proteins. IPI accession numbers listed in Supplementary Table 2 of [@ref-108] ([@ref-108]) were converted to UniProt IDs using the DAVID conversion tool.

`MCZ+13`: [@ref-75] ([@ref-75]) used laser capture microdissection (LCM) to separate stromal cells from 8 colon adenocarcinoma and 8 non-neoplastic tissue samples, which were pooled and analyzed by iTRAQ to identify 70 differentially expressed proteins. Here, gi numbers listed in Table 1 of [@ref-75] ([@ref-75]) were converted to UniProt IDs using the UniProt mapping tool; FASTA sequences of 31 proteins not found in UniProt were downloaded from NCBI and amino acid compositions were added to `human2.aa.csv`.

`KWA+14`: [@ref-57] ([@ref-57]) used differential biochemical extraction to isolate the chromatin-binding fraction in frozen samples of colon adenomas (3 patients) and carcinomas (5 patients), and LC-MS/MS was used for protein identification and label-free quantification. The results were combined with a database search to generate a list of 106 proteins with nuclear annotations and at least a three-fold expression difference. Here, gene names from Table 2 of [@ref-57] ([@ref-57]) were converted to UniProt IDs.

`UNS+14`: [@ref-97] ([@ref-97]) analyzed 30 samples of colorectal adenomas and paired normal mucosa using iTRAQ labeling, OFFGEL electrophoresis and LC-MS/MS. 111 proteins with expression fold changes (log~2~) at least ±0.5 and statistical significance threshold *q* \< 0.02 that were also quantified in cell-line experiments were classified as "epithelial cell signature proteins". UniProt IDs were taken from Table III of [@ref-97] ([@ref-97]).

`WKP+14`: [@ref-25] ([@ref-25]) analyzed the secretome of paired CRC and normal tissue from 4 patients, adopting a five-fold enrichment cutoff for identification of candidate biomarkers. Here, the list of proteins from Supplementary Table 1 of [@ref-25] ([@ref-25]) was filtered to include those with at least five-fold greater or lower abundance in CRC samples and *p* \< 0.05. Two proteins listed as "Unmapped by Ingenuity" were removed, and gene names were converted to UniProt IDs using the UniProt mapping tool.

`STK+15`: [@ref-89] ([@ref-89]) analyzed the membrane-enriched proteome from tumor and adjacent normal tissues from 8 patients using label-free nano-LC-MS/MS to identify 184 proteins with a fold change \> 1.5 and *p*-value \< 0.05. Here, protein identifiers from Supporting Table 2 of [@ref-89] ([@ref-89]) were used to find the corresponding UniProt IDs.

`WDO+15`: [@ref-104] ([@ref-104]) analyzed 8 matched formalin-fixed and paraffin-embedded (FFPE) samples of normal tissue (N) and adenocarcinoma (C) and 16 nonmatched adenoma samples (A) using LC-MS to identify 2300 (N/A), 1780 (A/C) and 2161 (N/C) up- or down-regulated proteins at *p* \< 0.05. The list of proteins used in this study includes only those marked as having a significant change in SI Table 3 of [@ref-104] ([@ref-104]).

`LPL+16`: [@ref-64] ([@ref-64]) used iTRAQ and 2D LC-MS/MS to analyze pooled samples of stroma purified by laser capture microdissection (LCM) from 5 cases of non-neoplastic colonic mucosa (NC), 8 of adenomatous colon polyps (AD), 5 of colon carcinoma *in situ* (CIS) and 9 of invasive colonic carcinoma (ICC). A total of 222 differentially expressed proteins between NC and other stages were identified. Here, gene symbols from Supplementary Table S3 of [@ref-64] ([@ref-64]) were converted to UniProt IDs using the UniProt mapping tool.

`PHL+16`: [@ref-79] ([@ref-79]) used iTRAQ 2D LC-MS/MS to analyze pooled samples from 5 cases of normal colonic mucosa (NC), 8 of adenoma (AD), 5 of carcinoma *in situ* (CIS) and 9 of invasive colorectal cancer (ICC). A total of 326 proteins with differential expression between two successive stages (and, for CIS and ICC, also differentially expressed with respect to NC) were detected. The list of proteins used in this study was generated by converting the gene names in Supplementary Table 4 of [@ref-79] ([@ref-79]) to UniProt IDs using the UniProt mapping tool.

Basis I
-------

To formulate a thermodynamic description of a chemically reacting system, an important choice must be made regarding the basis species used to describe the system. The basis species, like thermodynamic components, are a minimum number of chemical formula units that can be linearly combined to generate the composition of any chemical species in the system of interest. Stated differently, any species can be formed by combining the components, but components can not be used to form other components ([@ref-98], [@ref-98]). Within these constraints, any specific choice of a basis is theoretically permissible. In making the choice of components, convenience ([@ref-34], [@ref-34]), ease of interpretation and relationship with measurable variables, as well as availability of thermodynamic data (e.g., [@ref-41], [@ref-41]), and kinetic favorability ([@ref-70], [@ref-70]) are other useful considerations. Once the basis species are chosen, the stoichiometric coefficients in the formation reaction for any chemical species are algebraically determined.

Following previous studies (e.g., [@ref-26], [@ref-26]), the basis species initially chosen here are CO~2~, H~2~O, NH~3~, H~2~S and O~2~ (Basis I). The reaction representing the overall formation from these basis species of a protein having the formula C~*c*~H~*h*~N~*n*~O~*o*~S~*s*~ is $$\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$), which is used here because proteins in the comparisons generally have different sequence lengths.

These or similar sets of inorganic species (such as H~2~ instead of O~2~) are often used in studying reaction energetics in geobiochemistry (e.g., [@ref-90], [@ref-90]). However, as seen in [Figs. 1A](#fig-1){ref-type="fig"} and [1B](#fig-1){ref-type="fig"}, there is a high correlation between *Z*~C~ of protein molecules and $\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ and not *Z*~C~). Because of this stoichiometric interdependence, changes in either redox or hydration potential, while holding the chemical potentials of the remaining basis species constant, have correlated effects on the energetics of chemical transformations (see 'Comparison with inorganic basis species' below). A different set of basis species can be chosen that reduces this correlation and affords a more informative description of the compositional changes in proteomic transformations.
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Data are plotted for (A, C) individual human proteins and (B,D) mean composition of proteins from microbial genomes, with $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ computed using (A, B) Basis I (Reaction ([R1](#eqn-R1){ref-type="disp-formula"})) or (C, D) Basis II (Reaction ([R2](#fdR2){ref-type="disp-formula"})). Linear least-squares fits and *R*^2^ values are shown. In (A) and (C), the intensity of shading corresponds to density of points, produced using the `smoothScatter()` function of R graphics ([@ref-80], [@ref-80]). The label in plot (A) identifies a particular protein, MUC1, which is used for the example calculations (see Reactions ([R3](#fdR3){ref-type="disp-formula"}) and ([R4](#fdR4){ref-type="disp-formula"})).](peerj-04-2238-g001){#fig-1}

Basis II
--------

In this exploratory study, we restrict attention to at most two variables, with the implication that the others are held constant. In a subcellular setting, assuming that the chemical potentials of CO~2~, NH~3~ and H~2~S do not change during a proteomic transformation, as implied by varying the chemical potentials of O~2~ and H~2~O in Basis I, may be less appropriate than assuming constant chemical potentials of more complex metabolites. In thermodynamic models for systems of proteins, constant chemical activities of chemical components having the compositions of amino acids might be a reasonable provision.

Although 1140 3-way combinations can be made of the 20 common proteinogenic amino acids, only 324 of the combinations contain cysteine and/or methionine (one of these is required to provide sulfur), and of these only 300, when combined with O~2~ and H~2~O, are compositionally nondegenerate. The slope, intercept and *R*^2^ of the linear least-squares fits between *Z*~C~ and $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ using each possible basis containing O~2~, H~2~O and three amino acids are listed in file `AAbasis.csv` in [Dataset S1](#supp-1){ref-type="supplementary-material"}. Many of these combinations have lower *R*^2^ and lower slopes than found for Basis I ([Figs. 1A](#fig-1){ref-type="fig"} and [1B](#fig-1){ref-type="fig"}), indicating a decreased correlation. From those with a lower correlation, but not the lowest, the basis including cysteine (Cys), glutamic acid (Glu), glutamine (Gln), O~2~ and H~2~O (Basis II) has been selected for use in this study. The scatterplots and fits between *Z*~C~ and $\documentclass[12pt]{minimal}
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A secondary consideration in choosing this basis instead of others with even lower *R*^2^ is the centrality of glutamine and glutamic acid in many metabolic pathways (e.g., [@ref-23], [@ref-23]). Accordingly, these amino acids may be kinetically more reactive than others in pathways of protein synthesis and degradation. The presence of side chains derived from cysteine and glutamic acid in the abundant glutathione molecule (GSH), associated with redox homeostasis, is also suggestive of a central metabolic requirement for these amino acids. Again, it must be stressed that the current provisional choice of basis species is neither uniquely determined nor necessarily optimal for a thermodynamic description of any particular system. More experience with thermodynamic modeling and better biochemical intuition will likely provide reasons to refine these calculations using a different basis, perhaps including metabolites other than amino acids.

A general formation reaction using Basis II is $$\documentclass[12pt]{minimal}
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where the reaction coefficients (*n*~Cys~, *n*~Glu~, *n*~Gln~, *n*~H~2~O~ and *n*~O~2~~) can be obtained by solving $$\documentclass[12pt]{minimal}
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The combination of molecules shown in Reaction ([R2](#fdR2){ref-type="disp-formula"}) does not represent the actual mechanism of synthesis of the proteins. Instead, reactions such as this account for mass-conservation requirements and permit the subsequent generation of thermodynamic models for the potential for formation of different proteins as a function of system parameters (i.e., chemical potentials of O~2~ and H~2~O).

As an example of a specific calculation, consider the following reaction for MUC1, a chromatin-binding protein that is highly up-expressed in CRC cells ([@ref-57], [@ref-57]). $$\documentclass[12pt]{minimal}
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As with the other reactions shown above, this reaction is not a mechanism, but represents the stoichiometric requirements for the formation from the basis species of one mole of the protein. Water is released in Reaction ([R3](#fdR3){ref-type="disp-formula"}), so the water demand (*n*~H~2~O~) is negative. The length of this protein is 1,255 amino acid residues, giving the water demand per residue, $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}=-895.2/1,255=-0.71$\end{document}$. The average oxidation state of carbon (*Z*~C~) in MUC1, which does not depend on the choice of basis species, is 0.005 ([Eq. 1](#eqn-1){ref-type="disp-formula"}). The value of *Z*~C~ indicates that MUC1 is a relatively highly oxidized protein, while its $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ places it near the median water demand for up-expressed proteins in cancer in this dataset (see [Fig. 2A](#fig-2){ref-type="fig"} below).
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Thermodynamic calculations
--------------------------

Standard molal thermodynamic properties of the amino acids and unfolded proteins estimated using amino acid group additivity were calculated as described by [@ref-28] ([@ref-28]), taking account of updated values for the methionine sidechain group ([@ref-61], [@ref-61]). In this study, the Gibbs energies of hypothetically non-ionized proteins were used, and calculations were carried out at 37 °C and 1 bar. The temperature dependence of standard Gibbs energies was calculated using the revised Helgeson--Kirkham--Flowers (HKF) equations of state ([@ref-42], [@ref-42]; [@ref-93], [@ref-93]). Thermodynamic properties for O~2~ (gas) were calculated using data from [@ref-99] ([@ref-99]) and the Maier--Kelley heat capacity function ([@ref-53], [@ref-53]). Properties of liquid H~2~O were calculated using data and extrapolations coded in Fortran subroutines from the SUPCRT92 package ([@ref-51], [@ref-51]), as provided in the CHNOSZ package ([@ref-26], [@ref-26]).

Chemical affinities of reactions were calculated using activities of amino acids in the basis equal to 10^−4^, and activities of proteins equal to 1/(protein length) (i.e., unit activity of amino acid residues). Continuing with the example of Reaction ([R3](#fdR3){ref-type="disp-formula"}), an estimate of the standard Gibbs energy ($\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }{G}_{f}^{o}$\end{document}$) of the aqueous protein molecule ([@ref-28], [@ref-28]; [@ref-61], [@ref-61]) at 37 °C is −40, 974 kcal/mol; combined with the standard Gibbs energies of the basis species, this give a standard Gibbs energy of reaction ($\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }{G}_{r}^{o}$\end{document}$) equal to 66,889 kcal/mol. At log*a*~H~2~O~ = 0 and log*f*~O~2~~ = − 65, with activities of the amino acid basis species equal to 10^−4^ , the overall Gibbs energy (Δ*G*~*r*~) is 24,701 kcal/mol. The negative of this value is the chemical affinity (*A*) of the reaction. The per-residue chemical affinity for formation of protein MUC1 in the stated conditions is −19.7 kcal/mol. (This calculation can be reproduced using the function `reaction()` in file `plot.R` in [Dataset S1](#supp-1){ref-type="supplementary-material"}.)

In a given system, proteins with higher (more positive) chemical affinity are relatively energetically stabilized, and theoretically have a higher propensity to be formed. Therefore, the differences in affinities reflect not only the amino acid compositions of the protein molecules but also the potential for local environmental conditions to influence the relative abundances of proteins.

Weighted rank difference
------------------------

The contours on relative stability diagrams for the groups of differentially expressed proteins (see [Fig. 6](#fig-6){ref-type="fig"} below) depict the weighted rank differences of chemical affinities of formation of proteins. To illustrate this calculation, consider a hypothetical system composed of 3 proteins with higher expression in cancer (C) and 4 with higher expression in normal samples (down-expressed in cancer, i.e., having higher expression in a healthy state) (H). Suppose that under one set of conditions (i.e., specified log*a*~H~2~O~ and log*f*~O~2~~), the per-residue affinities of the proteins give the following ranking in ascending order (I): $$\documentclass[12pt]{minimal}
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This gives as the sum of ranks for up-expressed (C) proteins ∑*r*~C~ = 6, and for down-expressed (H) proteins ∑*r*~H~ = 22. The difference in sum of ranks is Δ*r*~C−H~ = − 16; the negative value is associated with a higher rank sum for the down-expressed proteins, indicating that these as a group are more stable than the down-expressed proteins. In a second set of conditions, we might have (II): $$\documentclass[12pt]{minimal}
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For systems where the numbers of proteins in the two groups are equal, the maximum possible differences in rank sums would have equal absolute values, but that is not the case in this and other systems having unequal numbers of up- and down-expressed proteins. To characterize these datasets, the weighted rank-sum difference can be calculated using $$\documentclass[12pt]{minimal}
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}{}\begin{eqnarray*}\mrm{\Delta }\overline{r}=2 \left( \frac{{n}_{\mathrm{H}}}{n} \sum {r}_{\mathrm{C}}- \frac{{n}_{\mathrm{C}}}{n} \sum {r}_{\mathrm{H}} \right) \end{eqnarray*}\end{document}$$where *n*~H~, *n*~C~ and *n* are the numbers of down-expressed, up-expressed, and total proteins in the comparison. In the example here, we have *n*~H~∕*n* = 4∕7 and *n*~C~∕*n* = 3∕7. [Equation (3)](#eqn-3){ref-type="disp-formula"} then gives $\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }\overline{r}=12$\end{document}$, respectively, for conditions (I) and (II) above, showing equal weighted rank-sum differences for the two extreme rankings.

We can also consider a situation where the ranks of the proteins are evenly distributed: $$\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }\overline{r}=0$\end{document}$. The zero value for an even distribution and the opposite values for the two extremes demonstrate the applicability of this weighting scheme.

Software and data availability
------------------------------

All statistical and thermodynamic calculations were performed using R ([@ref-80], [@ref-80]). Thermodynamic calculations were carried out using R package CHNOSZ ([@ref-26], [@ref-26]). Effect sizes (see below) were calculated using R package orddom ([@ref-84], [@ref-84]). Figures were generated using CHNOSZ and graphical functions available in R together with the R package colorspace ([@ref-48], [@ref-48]) for constructing an HCL-based color palette ([@ref-110], [@ref-110]). With the mentioned packages installed, [Table 1](#table-1){ref-type="table"} and the figures in this paper can be reproduced using the code (`plot.R`) and data files (`*.csv`) in [Dataset S1](#supp-1){ref-type="supplementary-material"}.

Results
=======

Compositional comparisons of human proteins
-------------------------------------------

Comparisons of proteome composition in terms of average oxidation state of carbon (*Z*~C~) and water demand per residue ($\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$) are presented in [Fig. 2](#fig-2){ref-type="fig"} and [Table 1](#table-1){ref-type="table"}. [Figure 2](#fig-2){ref-type="fig"} shows scatterplots of individual protein compositions for proteomes in three representative studies. Each of these exhibits a strongly differential trend in *Z*~C~ or $\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ that can be visually identified. In [Fig. 2A](#fig-2){ref-type="fig"}, chromatin-binding proteins highly expressed in carcinoma ([@ref-57], [@ref-57]) as a group exhibit a lower *Z*~C~ than those found to be more abundant in adenoma. In [Fig. 2B](#fig-2){ref-type="fig"}, proteins relatively highly expressed in epithelial cells in adenoma ([@ref-97], [@ref-97]) tend to have higher $\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ than the proteins more highly expressed in paired normal tissues. Differentially expressed proteins between adenoma and normal tissue identified in a recent deep-proteome analysis ([@ref-104], [@ref-104]) are compared in [Fig. 2C](#fig-2){ref-type="fig"}, showing that proteins up-expressed in adenoma are relatively oxidized (i.e., have higher *Z*~C~).

In order to quantify these differences, [Table 1](#table-1){ref-type="table"} shows the numbers of proteins in each comparison (*n*~1~ for normal or less advanced cancer stage; *n*~2~ for tumor or more advanced cancer stage), differences of means (MD), common language effect size as percentages (ES), and *p*-values calculated using the Wilcoxon rank sum test. This non-parametric test is suitable for data which may not be normally distributed. For a given experiment, the common language effect size, or probability of superiority, describes the probability that *Z*~C~ or $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ of proteins in the *n*~2~ compared to *n*~1~ groups. The ES and *p*-value are used here to allow for a subjective assessment of the compositional differences. ES values ≥60 or ≤40 and *p*-values \< 0.05 are highlighted in the table. The corresponding mean differences are underlined for *p* \< 0.05, or bolded if ES is also ≥60 or ≤40. These cutoffs highlight datasets with the largest and most significant differences in *Z*~C~ and $\documentclass[12pt]{minimal}
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Counting the underlined and bolded MD values in [Table 1](#table-1){ref-type="table"}, the number of datasets with a significant difference in *Z*~C~ (18) is greater than those with a significant difference in $\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ (10). Of the 10 unique studies yielding at least one dataset with a significant difference in *Z*~C~ in a comparison with normal tissue, 8 exhibit a higher mean value in adenoma or carcinoma compared to normal tissue. One of the other studies ([@ref-9], [@ref-9]) has datasets with higher mean *Z*~C~ in proteins up-expressed in adenoma, but lower mean *Z*~C~ in proteins up-expressed in stage II and III carcinoma, compared to normal tissue. A second study, which analyzed proteins in stromal cells ([@ref-64], [@ref-64]), shows a significantly lower *Z*~C~ in adenoma compared to normal tissue.

Most of the studies analyzed proteins in whole or microdissected tissue, but two datasets in studies from the same laboratory represent the nuclear matrix or chromatin-binding fraction ([@ref-4], [@ref-4]; [@ref-57], [@ref-57]). These two datasets give lower mean *Z*~C~ of proteins more highly expressed in carcinoma than adenoma. One other dataset has a lower mean *Z*~C~ of proteins up-expressed in carcinoma compared to adenoma ([@ref-104], [@ref-104]), and one has a higher mean value ([@ref-72], [@ref-72]).
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Natural variability inherent in the heterogeneity of tumors, as well as differences in experimental design and technical analysis, may underlie the opposite trends in *Z*~C~ between some datasets that compare the same stages of cancer. However, there is a preponderance of datasets with higher values of *Z*~C~ and $\documentclass[12pt]{minimal}
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Compositional comparisons of microbial proteins
-----------------------------------------------

Summary data on microbial populations from four studies were selected for comparison here. First, in a study of 16S RNA of fecal microbiota, [@ref-100] ([@ref-100]) reported genera that are significantly increased or decreased in CRC compared to healthy patients. In order to compare the chemical compositions of the microbial populations, single species with sequenced genomes were chosen to represent each of these genera (see [Table 2](#table-2){ref-type="table"}). Where possible, the species selected are those mentioned by [@ref-100] ([@ref-100]) as being significantly altered, or are species reported in other studies to be present in healthy or cancer states (see [Table 2](#table-2){ref-type="table"}).

In the second study considered ([@ref-112], [@ref-112]), changes in the metagenomic abundance of fecal microbiota associated with CRC were analyzed for their potential as a biosignature for cancer detection. The species shown in Fig. 1A of [@ref-112] ([@ref-112]) with a log odds ratio greater than 0.15 were selected for comparison, and are listed in [Table 3](#table-3){ref-type="table"}. [@ref-112] ([@ref-112]) found a strong enrichment of *Fusobacterium* in cancer, consistent with previous reports ([@ref-59], [@ref-59]; [@ref-18], [@ref-18]). In a third study, [@ref-17] ([@ref-17]) reported the findings of a network analysis that identified 5 microbial "co-abundance groups" at the genus level. As before, single representative species were selected in this study, and are listed in [Table 2](#table-2){ref-type="table"}. Except for the presence of *Fusobacterium*, the co-abundance groups show little genus-level overlap with community profiles derived from the previous two studies.

10.7717/peerj.2238/table-2

###### Microbial species selected as models for genera and co-abundance groups that differ between CRC and healthy patients.

![](peerj-04-2238-g008)

  Phylum                                                                                                     Species                                        Abbrv.   Bioproject                                                              Refs.
  ---------------------------------------------------------------------------------------------------------- ---------------------------------------------- -------- ----------------------------------------------------------------------- ------------------------------------
  ***Model species for genera significantly higher in healthy patients***[^a^](#table-2fn1){ref-type="fn"}                                                                                                                                   
  Bacteroidetes                                                                                              *Bacteroides vulgatus* ATCC 8482               Bvu      [PRJNA13378](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA13378)   [^c^](#table-2fn3){ref-type="fn"}
  Bacteroidetes                                                                                              *Bacteroides uniformis* ATCC 8492              Bun      [PRJNA18195](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA18195)   [^c^](#table-2fn3){ref-type="fn"}
  Firmicutes                                                                                                 *Roseburia intestinalis* L1-82 (DSM 14610)     Rin      [PRJNA30005](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA30005)   [^d^](#table-2fn4){ref-type="fn"}
  Bacteroidetes                                                                                              *Alistipes indistinctus* YIT 12060             Ain      [PRJNA46373](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA46373)   [^c^](#table-2fn3){ref-type="fn"}
  Firmicutes                                                                                                 *Eubacterium rectale* ATCC 33656               Ere      [PRJNA29071](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA29071)   [^e^](#table-2fn5){ref-type="fn"}
  Proteobacteria                                                                                             *Parasutterella excrementihominis* YIT 11859   Pex      [PRJNA48497](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA48497)   [^f^](#table-2fn6){ref-type="fn"}
  ***Model species for genera significantly higher in CRC patients***[^a^](#table-2fn1){ref-type="fn"}                                                                                                                                       
  Bacteroidetes                                                                                              *Porphyromonas gingivalis* W83                 Pgi      [PRJNA48](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA48)         [^g^](#table-2fn7){ref-type="fn"}
  Proteobacteria                                                                                             *Escherichia coli* NC101                       Eco      [PRJNA47121](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA47121)   [^c,h^](#table-2fn){ref-type="fn"}
  Firmicutes                                                                                                 *Enterococcus faecalis* V583                   Efa      [PRJNA57669](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA57669)   [^c^](#table-2fn3){ref-type="fn"}
  Firmicutes                                                                                                 *Streptococcus infantarius* ATCC BAA-102       Sin      [PRJNA20527](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA20527)   [^i^](#table-2fn9){ref-type="fn"}
  Firmicutes                                                                                                 *Peptostreptococcus stomatis* DSM 17678        Pst      [PRJNA34073](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA34073)   [^j^](#table-2fn10){ref-type="fn"}
  Bacteroidetes                                                                                              *Bacteroides fragilis* YCH46                   Bfr      [PRJNA58195](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA58195)   [^g^](#table-2fn7){ref-type="fn"}
  ***Model species for protective co-abundance groups***[^b^](#table-2fn2){ref-type="fn"}                                                                                                                                                    
  Actinobacteria                                                                                             *Bifidobacterium longum* NCC2705               Blo      [PRJNA57939](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA57939)   [^g,k^](#table-2fn){ref-type="fn"}
  Firmicutes                                                                                                 *Faecalibacterium prausnitzii* SL3/3           Fpr      [PRJNA39151](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA39151)   [^e,l^](#table-2fn){ref-type="fn"}
  ***Model species for pro-carcinogenic co-abundance groups***[^b^](#table-2fn2){ref-type="fn"}                                                                                                                                              
  Fusobacteria                                                                                               *Fusobacterium nucleatum* ATCC 23726           Fnu      [PRJNA49043](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA49043)   [^m,n^](#table-2fn){ref-type="fn"}
  Bacteroidetes                                                                                              *Prevotella copri* DSM 18205                   Pco      [PRJNA30025](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA30025)   [^k,o^](#table-2fn){ref-type="fn"}
  Firmicutes                                                                                                 *Coprobacillus* sp. D7                         Csp      [PRJNA32495](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA32495)   [^h^](#table-2fn8){ref-type="fn"}

**Notes.**

Genus identification from Table 2 of [@ref-100] ([@ref-100]). Based on comments in [@ref-100] ([@ref-100]), *Bacteroides* is represented here by two species (*B. vulgatus* and *B. uniformis*) in healthy patients, and one species (*B. fragilis*) in CRC patients.

Genus-level definition of co-abundance groups from [@ref-17] ([@ref-17]).

[@ref-100] ([@ref-100]); species closely related to 16S rRNA-derived operational taxonomic units (OTUs; Fig. 2 of [@ref-100], [@ref-100]) or otherwise mentioned by those authors (*E. faecalis*).

[@ref-29] ([@ref-29]).

[@ref-66] ([@ref-66]).

[@ref-77] ([@ref-77]).

[@ref-20] ([@ref-20]).

[@ref-17] ([@ref-17]).

[@ref-11] ([@ref-11]).

[@ref-112] ([@ref-112]).

[@ref-103] ([@ref-103]).

[@ref-91] ([@ref-91]).

[@ref-18] ([@ref-18]).

[@ref-59] ([@ref-59]).

cf. [@ref-20] ([@ref-20]) and [@ref-17] ([@ref-17]) (more abundant in CRC patients); [@ref-103] ([@ref-103]) (more abundant in healthy subjects).

10.7717/peerj.2238/table-3

###### Species from a consensus microbial signature for CRC classification of fecal metagenomes ([@ref-112], [@ref-112]).

Only species reported as having a log odds ratio larger than ±0.15 are listed here, together with strains and Bioproject IDs used as models in the present study.

![](peerj-04-2238-g009)

  Species                                      Strain                                          Abbrv.   Bioproject
  -------------------------------------------- ----------------------------------------------- -------- -----------------------------------------------------------------------
  **Higher in CRC patients**                                                                            
  *Fusobacterium nucleatum* subsp. vincentii   ATCC 49256                                      Fnv      [PRJNA1419](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1419)
  *Fusobacterium nucleatum* subsp. animalis    D11                                             Fna      [PRJNA32501](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA32501)
  *Peptostreptococcus stomatis*                DSM 17678                                       Pst      [PRJNA34073](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA34073)
  *Porphyromonas asaccharolytica*              DSM 20707                                       Pas      [PRJNA51745](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA51745)
  *Clostridium symbiosum*                      ATCC 14940                                      Csy      [PRJNA18183](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA18183)
  *Clostridium hylemonae*                      DSM 15053                                       Chy      [PRJNA30369](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA30369)
  *Lactobacillus salivarius*                   ATCC 11741                                      Lsa      [PRJNA31503](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA31503)
  **Higher in healthy patients**                                                                        
  *Clostridium scindens*                       ATCC 35704                                      Csc      [PRJNA18175](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA18175)
  *Eubacterium eligens*                        ATCC 27750                                      Eel      [PRJNA29073](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA29073)
  *Methanosphaera stadtmanae*                  DSM 3091                                        Mst      [PRJNA15579](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA15579)
  *Phascolarctobacterium succinatutens*        YIT 12067                                       Psu      [PRJNA48505](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA48505)
  unclassified *Ruminococcus* sp.              ATCC 29149([^a^](#table-3fn1){ref-type="fn"})   Rsp      [PRJNA18179](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA18179)
  *Streptococcus salivarius*                   SK126                                           Ssa      [PRJNA34091](http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA34091)

**Notes.**

*R. gnavus*.

Finally, [Table 4](#table-4){ref-type="table"} lists the "best aligned strain" from Supplementary Dataset 5 of [@ref-32] ([@ref-32]) for all species shown there with negative enrichment in cancer, and for selected species with positive enrichment in cancer. Although every uniquely named strain given by [@ref-32] ([@ref-32]) was used in the comparisons below (*n* = 44; see [Fig. 3D](#fig-3){ref-type="fig"} below), for clarity only the up-enriched species that appear in the calculated stability diagram (see [Fig. 4D](#fig-4){ref-type="fig"} below) are listed in [Table 4](#table-4){ref-type="table"} and labeled in [Fig. 3D](#fig-3){ref-type="fig"}. File `microbes.csv` in [Dataset S1](#supp-1){ref-type="supplementary-material"} contains the complete list of Bioproject IDs and calculated *Z*~C~ and $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$) for mean amino acid compositions of proteins in genomes of normal- and cancer-enriched microbes.\
Data are shown for representative species for (A) microbial genera identified in fecal 16s RNA ([@ref-100], [@ref-100]; [Table 2](#table-2){ref-type="table"} top), (B) microbial signatures in fecal metagenomes ([@ref-112], [@ref-112]; [Table 3](#table-3){ref-type="table"}), (C) microbial co-abundance groups ([@ref-17], [@ref-17]; [Table 2](#table-2){ref-type="table"} bottom), and (D) best aligned strains to metagenomic linkage groups in fecal samples ([@ref-32], [@ref-32]; [Table 4](#table-4){ref-type="table"}). The mean amino acid composition of proteins in the *Homo sapiens* genome (Hsa) is also shown.](peerj-04-2238-g003){#fig-3}

![Maximal relative stability diagrams for mean microbial protein compositions.\
Each stability field in these diagrams shows the ranges of oxygen fugacity and water activity (in log units: log*f*~O~2~~ and log*a*~H~2~O~) where the mean protein composition from the labeled microbial species has a higher per-residue affinity (lower Gibbs energy) of formation than the others. Blue and red shading designate microbes relatively enriched in samples from healthy donors and cancer patients, respectively. Plot (E) is a composite figure in which the intensity of shading corresponds to the number of overlapping healthy- or cancer-enriched microbes in the preceding diagrams.](peerj-04-2238-g004){#fig-4}

For each of the microbial species listed in [Tables 2](#table-2){ref-type="table"}--[4](#table-4){ref-type="table"}, a mean protein composition was calculated by combining amino acid sequences of all proteins downloaded from the NCBI genome page associated with the Bioproject IDs shown in the Tables (see file `microbial.aa.csv` in [Dataset S1](#supp-1){ref-type="supplementary-material"}). This method does not account for actual protein abundances in organisms, and excludes any post-translational modifications. Calculation of the mean amino acid composition of proteins in this way is not an exact representation of the cellular protein composition, but provides a starting point for identifying environmental signals in protein composition. Mean amino acid compositions or amino acid frequencies deduced from microbial genomes, calculated without weighting for actual protein abundance, have been used in many studies making evolutionary and/or environmental comparisons (e.g., [@ref-94], [@ref-94]; [@ref-111], [@ref-111]; [@ref-14], [@ref-14]). In the future, more refined calculations may be possible by using genome-wide estimates of protein expression levels based on codon usage patterns (e.g., [@ref-74], [@ref-74]; [@ref-14], [@ref-14]).
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###### Selected microbial species enriched or depleted in stool samples from cancer patients compared to healthy controls ([@ref-32], [@ref-32]).

![](peerj-04-2238-g010)

  Enriched species                             Abbrv.   Depleted species                 Abbrv.
  -------------------------------------------- -------- -------------------------------- --------
  *Bacteroides dorei*                          Bdo      *Actinomyces viscosus*           Avi
  *Bacteroides ovatus*                         Bov      *Bifidobacterium animalis*       Ban
  butyrate-producing bacterium SS3/4           But      *Clostridium* sp. SS2/1          Csp
  *Clostridium asparagiforme*                  Cas      *Ruminococcus* sp. 5_1\_39BFAA   Rsp
  *Fusobacterium* sp. oral taxon 370           Fsp      *Streptococcus mutans*           Smu
  *Lachnospiraceae* bacterium 3_1\_57FAA_CT1   L57      *Streptococcus thermophilus*     Sth
  *Paraprevotella clara*                       Pcl                                       
  *Peptostreptococcus stomatis*                Pst                                       
  *Ruminococcaceae* bacterium D16              Rba                                       
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$) vs. oxidation state of carbon (*Z*~C~) in the mean amino acid compositions of proteins from all of the microbial species considered here are plotted in [Figs. 1B](#fig-1){ref-type="fig"} and [1D](#fig-1){ref-type="fig"}, and for individual datasets in [Fig. 3](#fig-3){ref-type="fig"}. The groups of proteins in the microbes enriched in cancer patients have somewhat lower *Z*~C~ than those enriched in healthy donors in the same study. The dataset from [@ref-32] ([@ref-32]) ([Fig. 3D](#fig-3){ref-type="fig"}) shows a more complex distribution, where the microbes with a relative enrichment in healthy individuals form two clusters at high and low *Z*~C~. The *Fusobacterium* species identified in the studies of [@ref-112] ([@ref-112]), [@ref-17] ([@ref-17]) and [@ref-32] ([@ref-32]) have the lowest *Z*~C~ of any microbial species considered here. The mean human protein composition is also plotted in [Fig. 3](#fig-3){ref-type="fig"}, revealing a higher *Z*~C~ than any of the mean microbial proteins except for *Actinomyces viscosus* and *Bifidobacterium animalis*, identified in the study of [@ref-32] ([@ref-32]) ([Fig. 3D](#fig-3){ref-type="fig"}). The tendency for microbial organisms to be composed of more reduced biomolecules than the host may reflect the relatively reducing conditions in the gut.

Thermodynamic descriptions: background
--------------------------------------

Going beyond compositional comparisons, thermodynamic descriptions can account for stoichiometric and energetic constraints and provide a richer interpretation of proteomic data in the context of tumor microenvironments.

By combining both stoichiometric and energetic variables, a thermodynamic description of proteomic data reveals possible biochemical constraints that may arise within cells and in tumor microenvironments. To give an example of how relative stabilities of up- and down-expressed proteins in a proteomic dataset can be calculated as a function of chemical potentials, consider Reaction ([R3](#fdR3){ref-type="disp-formula"}) above written for the formation of one mole of MUC1. In order to compare proteins of different lengths, the formula of the protein is written per residue. The corresponding reaction is then $$\documentclass[12pt]{minimal}
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An expression for the chemical affinity ([@ref-58], [@ref-58]; [@ref-43], [@ref-43]) of Reaction ([R4](#fdR4){ref-type="disp-formula"}) is $$\documentclass[12pt]{minimal}
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}{}\begin{eqnarray*}\mathbi{A}=2.303RT\log \nolimits \left( K/Q \right) \end{eqnarray*}\end{document}$$where 2.303 is shorthand for the natural logarithm of 10, *R* is the gas constant, *T* is temperature, log represents the common (decimal) logarithm, and the activity quotient *Q* is given by $$\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }{G}_{r}^{o}$\end{document}$ is the standard Gibbs energy of the reaction. As noted above, the standard Gibbs energies of species used to calculate $\documentclass[12pt]{minimal}
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}{}$\mrm{\Delta }{G}_{r}^{o}$\end{document}$ at *T* = 37 °C are generated using amino acid group additivity for the proteins and published values for standard thermodynamic properties of the basis species in the reaction.

To compare the potential for formation of metastable molecules, the per-residue formulas of the proteins are assigned equal activities (1). Then, [Eqs. (4)](#eqn-4){ref-type="disp-formula"}--([5](#fd5){ref-type="disp-formula"}) show that the affinity, and hence relative potential for formation of different proteins, is a function of not only their amino acid composition (which determines the chemical formulas and standard Gibbs energies of the proteins used here), but also system parameters including temperature and the chemical potentials of the components. In this study, the chemical activities of the amino acid basis species are provisionally set to constant values (10^−4^), while log*f*~O~2~~ and log*a*~H~2~O~ are considered to be adjustable parameters that are used as exploratory variables. The ranges of these variables shown on the diagrams are selected in order to encompass the stability boundaries between groups of proteins differentially enriched in cancer and normal samples.

There are combinations of chemical activities of basis species in [Eq. (5)](#fd5){ref-type="disp-formula"} where the per-residue formation reactions of two proteins have an equal affinity, indicating equal chemical stability of the proteins. Other combinations of chemical activities of basis species give the result that one protein-residue formula has a higher affinity than the other(s), indicating greater stability of this protein. This concept provides an approach for constructing stability diagrams, which may be called the "maximum affinity method", that can be used to reproduce published equilibrium and metastable equilibrium diagrams for many inorganic and organic systems as shown by examples in the CHNOSZ package ([@ref-26], [@ref-26]) and is used below for microbial proteins. Because of the greater numbers of individual proteins in human proteomic datasets, a new method based on the difference in weighted sums of ranks of affinities is used here to compare the relative stabilities of groups of up- and down-expressed proteins in cancer.

Relative stability fields for microbial proteins
------------------------------------------------

Stability diagrams are shown in [Figs. 4A](#fig-4){ref-type="fig"}--[4D](#fig-4){ref-type="fig"} for the four sets of microbial proteins described above. The first diagram, representing significantly changed genera detected in fecal 16S rRNA ([@ref-100], [@ref-100]; first part of [Table 2](#table-2){ref-type="table"}), shows maximal stability fields for proteins from 5 species relatively enriched in healthy patients, and 3 species enriched in CRC patients. The other 4 proteins in the system are less stable than the others within the range of log*f*~O~2~~ and log*a*~H~2~O~ shown and do not appear on the diagram. The relative positions of the stability fields in [Fig. 4A](#fig-4){ref-type="fig"} are roughly aligned with the values of *Z*~C~ and $\documentclass[12pt]{minimal}
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}{}${\overline{n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$ *Peptostreptococcus stomatis*. Except for *E. coli*, the proteins from the species enriched in CRC occupy the lower log*f*~O~2~~ (reducing) and higher log*a*~H~2~O~ zones of this diagram.

In thermodynamic calculations for proteins from bacteria detected in fecal metagenomes ([@ref-112], [@ref-112]; [Table 3](#table-3){ref-type="table"}), the mean protein compositions of 3 of 6 healthy-enriched microbes and 4 of 7 cancer-enriched microbes exhibit maximal relative stability fields ([Fig. 4B](#fig-4){ref-type="fig"}). Here, the cancer-associated proteins occupy the more reducing (*Fusobacterium nucleatum* subsp. vincentii and subsp. animalis) or more oxidizing (*Clostridium hylemonae*, *Porphyromonas asaccharolytica*) regions, while the proteins from bacteria more abundant in healthy individuals are relatively stable at moderate oxidation--reduction conditions.

For the bacterial species representing microbial co-abundance groups ([@ref-17], [@ref-17]; second part of [Table 2](#table-2){ref-type="table"}), all of the 5 mean protein compositions are present on the diagram ([Figs. 4C](#fig-4){ref-type="fig"}). Here, the proteins from cancer-enriched bacteria are more stable at reducing conditions and those from healthy-enriched microbes are stabilized by oxidizing conditions.

A stability diagram for proteins of bacteria identified in a second metagenomic study ([@ref-32], [@ref-32]) shows a similar result ([Fig. 3D](#fig-3){ref-type="fig"}) for the 11 mean protein compositions with highest stability at some point the diagram. These patterns in relative stability again reflect the differences in *Z*~C~ of the proteins, although in this case, a greater proportion of proteins (33 out of the 44 included in the calculations) are not found to have maximal stability fields. The resulting stability diagram is therefore a more limited portrayal of the available data.

[Figure 4E](#fig-4){ref-type="fig"} is a composite representation of the calculations, in which higher cumulative counts of maximal stability of proteins from bacteria enriched in normal and cancer samples in the four studies are represented by deeper blue and red shading, respectively. According to this diagram, the chemical conditions predicted to be most favorable for the formation of proteins in many bacteria enriched in CRC are characterized by low log*f*~O~2~~. Proteins from bacteria that are abundant in healthy patients tend to be stabilized by moderate values of log*f*~O~2~~. Despite the differences in experimental design and microbial identification between studies, the thermodynamic calculations reveal a shared pattern of relative stabilities among the four datasets considered here.

![Calculated chemical affinities per residue of proteins in the `KWA+14` dataset.\
Values for individual proteins as a function of log*f*~O~2~~ at log*a*~H~2~O~ = 0 are shown in plot (A) as deviations from the mean value for all proteins. Down- and up-expressed proteins in carcinoma compared to adenoma are indicated by solid blue and dashed red lines, respectively. Plot (B) shows the difference in mean value between down- and up-expressed proteins (straight line and left-hand *y*-axis) and the weighted difference in sums of ranks of affinities as a percentage of maximum possible rank-sum difference ([Eq. (3)](#eqn-3){ref-type="disp-formula"}; curved line and right-side *y*-axis). Positive values of affinity or rank-sum difference in plot (B) correspond to relatively greater stability of the up-expressed proteins.](peerj-04-2238-g005){#fig-5}

Relative stability fields for human proteins
--------------------------------------------

Diagrams like those shown above that portray the maximally stable protein compositions are inadequate for analysis of larger datasets such as those generated in proteomic studies. It is apparent in [Fig. 5](#fig-5){ref-type="fig"} that only three different proteins up-expressed in cancer, from the 106 proteins in the `KWA+14` dataset (chromatin-binding proteins in carcinoma/adenoma), are maximally stable across a range of log*f*~O~2~~. However, visual inspection reveals a differential sensitivity to oxygen fugacity in the whole dataset, with lower log*f*~O~2~~ providing relatively higher potential for the formation of many of the up-expressed proteins in carcinoma samples. How can these responses be quantified in order to explore the data in multiple dimensions, including both log*a*~H~2~O~ and log*f*~O~2~~?

In [Fig. 5B](#fig-5){ref-type="disp-formula"}, the difference in mean values of chemical affinity per residue of carcinoma and adenoma-associated proteins appears as a straight line as a function of log*f*~O~2~~. This linear behavior would translate to evenly spaced isostability (taken as constant mean affinity difference) contours on a log*f*~O~2~~--log*a*~H~2~O~ diagram. The weighted rank difference of affinities (see Methods), shown by the curved line [Fig. 5B](#fig-5){ref-type="disp-formula"}, is a summary function that is more informative of changing chemical conditions. The variable slope is greatest near the zone of convergence for affinities of individual proteins ([Fig. 5A](#fig-5){ref-type="disp-formula"}), corresponding to the transition zone between groups of proteins. The resulting two-dimensional stability diagrams shown below have curved and diversely spaced isostability (taken as constant weighted rank difference of affinity) contours.

The diagrams in [Fig. 6](#fig-6){ref-type="fig"} portray weighted rank differences of chemical affinities of formation between groups of up- and down-expressed proteins reported for proteomic experiments. These combined depictions of stoichiometric and energetic differences constitute a theoretical prediction of the relative chemical (not conformational) stabilities of the proteins.

![Weighted rank-sum comparisons of chemical affinities of formation of human proteins as a function of log*f*~O~2~~ and log*a*~H~2~O~.\
The solid lines indicate equal ranking of proteins in the "normal" and "cancer" groups ([Table 1](#table-1){ref-type="table"}), and dotted contours are drawn at 10% increments of the maximum possible rank-sum difference. Blue and red areas correspond to higher ranking of cancer- and normal-enriched proteins, respectively, with the intensity of the shading increasing up to 50% the maximum possible rank-sum difference. (For readers without a color copy: the stability fields for proteins up-expressed in cancer lie above (A--D), to the right of (E--G), or to the left of (H) the stability fields for proteins with higher expression in normal tissue.) Panel (I) shows calculated values of Eh over the same ranges of log*f*~O~2~~ and log*a*~H~2~O~ (cf. Reaction ([R5](#eqn-R5){ref-type="disp-formula"})).](peerj-04-2238-g006){#fig-6}

The slopes of the equal-stability lines and the positions of the stability fields reflect the magnitude and sign of differences in *Z*~C~ and $\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$; the nearly horizontal lines show that relative stabilities are accordingly more sensitive to log*a*~H~2~O~ than log*f*~O~2~~. The second row depicts relative stabilities in the three datasets from [@ref-72] ([@ref-72]), which have large changes in, sequentially, $\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$, *Z*~C~, then both of these ([Table 1](#table-1){ref-type="table"}). Accordingly, the equal-stability lines for these datasets are closer to horizontal, closer to vertical, or have a more diagonal trend ([Figs. 6D](#fig-6){ref-type="fig"}--[6F](#fig-6){ref-type="fig"}).

The last row shows results for datasets that are characterized by large changes in *Z*~C~; the relative stabilities depend strongly on log*f*~O~2~~. According to [Fig. 6G](#fig-6){ref-type="fig"}, higher oxygen fugacity increases the relative potential for the formation of proteins up-expressed in cancer (dataset of [@ref-49], [@ref-49]). However, in a dataset for up- and down-expressed chromatin-binding proteins in carcinoma ([@ref-57], [@ref-57]), lower log*f*~O~2~~ is predicted to promote formation of the proteins up-expressed in carcinoma. This is the opposite trend to that found for most of the other datasets with significant differences in *Z*~C~. These opposing trends might be attributed to different biochemical constraints acting at the subcellular and cellular or tissue levels during carcinogenesis.

The full set of diagrams for all datasets listed in [Table 1](#table-1){ref-type="table"} is provided in [Fig. S1](#supp-2){ref-type="supplementary-material"}. It is notable that for the datasets where the relative stabilities are strongly a function of log*a*~H~2~O~ (sub-horizontal lines), the equal-stability lines are within a few log units of 0 (unit activity). Equal-stability lines that are diagonal often cross unit activity of H~2~O at a moderate value of log*f*~O~2~~, near −65 to −60 (see [Fig. S1](#supp-2){ref-type="supplementary-material"}). This could be indicative of a tendency for these proteomic transformations to be partially buffered by other redox reactions in the cell, and/or by liquid-like H~2~O with close to unit activity.

Effective values of oxidation--reduction potential (Eh) can be calculated by considering the water dissociation reaction, i.e., $$\documentclass[12pt]{minimal}
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}{}\begin{eqnarray*}{\mathrm{H}}_{2}\mathrm{O}\rightleftharpoons \frac{1}{2} {\mathrm{O}}_{2}+2{\mathrm{H}}^{+}+2{e}^{-}.\end{eqnarray*}\end{document}$$If one assumes that log*a*~H~2~O~ = 0 (unit water activity, as in an infinitely dilute solution), this reaction can be used to interconvert log*f*~O~2~~, pH and pe (or, in conjunction with the Nernst equation, Eh) (e.g., [@ref-33], [@ref-33], p. 176; [@ref-7], [@ref-7], p. 363). However, in the approach utilized here for assessing the relative stabilities of proteins in a subcellular context, no such assumptions are made on the operational value of log*a*~H~2~O~. Instead, it is used as an indicator of the internal state of the system, and is not necessarily buffered by an aqueous solution. Consequently, the effective Eh is considered to be a function of variable log*f*~O~2~~ and log*a*~H~2~O~, as shown in [Fig. 6I](#fig-6){ref-type="fig"} for pH = 7.4 and *T* = 37 °C. This comparison gives some perspective on operationally reasonable ranges of log*f*~O~2~~ and log*a*~H~2~O~.

The subcellular reduction potential monitored by the reduced glutathione (GSH)/oxidized glutathione disulfide (GSSG) couple ranges from ca. −260 mV for proliferating cells to ca. −170 mV for apoptotic cells ([@ref-86], [@ref-86]), lying toward the middle part of the range of conditions shown in [Fig. 6](#fig-6){ref-type="fig"}. A physiologically plausible Eh value of −0.2 V, corresponding to log*f*~O~2~~ = − 62.8 at unit activity of H~2~O, is close to the stability transitions for many of the datasets considered here (see also [Fig. S1](#supp-2){ref-type="supplementary-material"}).

Comparison with inorganic basis species
---------------------------------------

Figures made using Basis I (inorganic basis species, e.g., Reaction ([R1](#eqn-R1){ref-type="disp-formula"})) are provided in the [Supplemental Information](#supplemental-information){ref-type="supplementary-material"} (human proteins: [Fig. S2](#supp-3){ref-type="supplementary-material"}; microbial proteins: [Fig. S3](#supp-4){ref-type="supplementary-material"}). The stability boundaries in log*a*~H~2~O~--log*f*~O~2~~ diagrams constructed using Basis I cluster around a common, positive slope, in contrast with the greater diversity of slopes appearing on the corresponding diagrams constructed using Basis II ([Fig. S1](#supp-2){ref-type="supplementary-material"}).

As noted above, all mathematically possible choices for the basis species of a system are thermodynamically valid, but it appears that Basis II affords a greater convenience for interpretation. That is, compared to Basis I, Basis II yields a greater degree of separation of the effects of changing chemical potentials of H~2~O and O~2~ under the assumption that the activities of the remaining basis species (inorganic species in Basis I, or amino acids in Basis II) are held constant. However, it is also notable that two of the diagrams constructed using Basis I ([Fig. S2](#supp-3){ref-type="supplementary-material"}), unlike the others, have nearly horizontal equal-stability lines, showing that increasing activity of H~2~O at constant activity of CO~2~, NH~3~, H~2~S and fugacity of O~2~ gives an energetic advantage to the formation of potential up-expressed serum biomarkers (dataset `JKMF10`; [@ref-50], [@ref-50]) and proteins up-expressed in an "epithelial cell signature" for adenoma (dataset `UNS+14`; [@ref-97], [@ref-97]). These datasets are also found to be among those having significantly differential water demand using Basis II ([Table 1](#table-1){ref-type="table"}; [Fig. S1](#supp-2){ref-type="supplementary-material"}). Based on the similar results for these datasets using different choices of chemical components, it can be suggested that the compositions of the differentially expressed proteins in these datasets are especially indicative of changes in hydration potential.

Discussion
==========

Among 35 proteomic datasets considered here ([Table 1](#table-1){ref-type="table"}), many have significantly higher values of average oxidation state of carbon (*Z*~C~) in proteins up-expressed in adenoma or carcinoma compared to normal tissue. While a decrease in oxidation state might be expected if the differential expression of proteins was to some extent an adaptation to hypoxic conditions in tumors, the observed increase is more consistent with potentially oxidizing subcellular conditions that may accompany mitochondrial generation of ROS.

Available data for the adenoma to carcinoma transition are less conclusive: different datasets have relatively higher ([@ref-72], [@ref-72]) or lower ([@ref-104], [@ref-104]) *Z*~C~ of up-expressed proteins in carcinoma. A trend toward more reduced proteins in carcinoma compared to adenoma is also apparent in datasets for nuclear matrix fractions in chromosomal instability (CIN-type) CRC ([@ref-4], [@ref-4]) and for chromatin-binding fractions ([@ref-57], [@ref-57]). It is possible that particular subtypes of cancer and/or subfractions of cells have patterns of protein expression during carcinogenesis that are chemically distinct from trends observed at the tissue level.

Some proteomic datasets are also available for stromal cells associated with tumor tissues. Data from one study ([@ref-75], [@ref-75]) are consistent with the generally observed higher *Z*~C~ of protein in tumors, but data from a pair of recent studies that analyzed cancer and stromal cells from the same set of tissues ([@ref-64], [@ref-64]; [@ref-79], [@ref-79]) show that the proteins up-expressed in stromal cells, but not tumor cells, of adenoma are reduced compared to normal cells. Also, proteins up-expressed in tumor cells, but not stromal cells from carcinoma *in situ*, have a relatively oxidized composition ([Table 1](#table-1){ref-type="table"}). If an opposing trend in *Z*~C~ between stromal and epithelial cells is indeed established, it might be evidence for a proteome-level manifestation of metabolic coupling ([@ref-68], [@ref-68]) between tissue compartments in cancer. The "lactate shuttle" between metabolically coupled cells can be characterized in part by the difference between oxidation states of carbon in lactate (*Z*~C~ = 0) and pyruvate (*Z*~C~ = 0.667) ([@ref-15], [@ref-15]). More work is needed to understand how the fluxes of anabolic precursors and catabolic products between tissue compartments might contribute to the differential oxidation states of carbon in proteins observed in cancer.

The datasets available for comparison of mean protein compositions of bacteria enriched in healthy subjects and cancer patients are characterized by lower *Z*~C~ in proteins of bacteria with higher abundance in cancer patients ([Fig. 3](#fig-3){ref-type="fig"}), and consequently stabilization of these proteins by lower oxygen fugacity (log*f*~O~2~~; [Fig. 4](#fig-4){ref-type="fig"}). This trend could be viewed as an adaptation of microbial communities to minimize the energetic costs of biomass synthesis in more reducing conditions. The opposite trends in *Z*~C~ for the human and bacterial proteins also raises the possibility that their mutual proteomic makeup is partially the result of a redox balance, or coupling.

Another major outcome of the compositional comparisons of human proteomes is the increase in water demand per residue ($\documentclass[12pt]{minimal}
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}{}${\bar {n}}_{{\mathrm{H}}_{2}\mathrm{O}}$\end{document}$) apparent in some datasets for CRC tissues and in a list of candidate biomarkers summarized in a literature review ([@ref-50], [@ref-50]) ([Table 1](#table-1){ref-type="table"}). Higher hydration levels in breast cancer tissues have been observed spectroscopically ([@ref-1], [@ref-1]), and it has been proposed that increased hydration plays a role in reversion to an embryological mode of growth ([@ref-71], [@ref-71]). The thermodynamic calculations used to generate [Fig. 6](#fig-6){ref-type="fig"} support the possibility that higher water activity increases the potential for formation of the proteins up-expressed in cancer relative to normal tissue.

Although the ranges of log*a*~H~2~O~ and log*f*~O~2~~ derived from the model indicate to some extent the hydration and oxidation states of the system, they can not be interpreted directly in terms of measurable concentrations of water and oxygen. There are astronomical differences between theoretical values of oxygen fugacity in thermodynamic models and actual concentrations or partial pressures of oxygen (e.g., [@ref-7], [@ref-7], p. 364--365). Partial pressures of oxygen in human arterial blood are around 90--100 mmHg, and approximate threshold values for physiological hypoxia include 10 mmHg for energy metabolism, 0.5 mmHg for mitochondrial oxidative phosphorylation, and 0.02 mmHg for full oxidation of cytochromes ([@ref-46], [@ref-46]). Assuming ideal mixing, the equivalent range of oxygen fugacities indicated by these measurements is log*f*~O~2~~ = − 4.57 to −0.88, higher by far than the values that delimit the relative stabilities of cancer- and normal-enriched proteins computed here.

Likewise, the ranges of log*a*~H~2~O~ calculated here deviate tremendously from laboratory-based determination of water activity or hydration levels. Water activity in saturated protein solutions is not lower than 0.5 ([@ref-56], [@ref-56]), and recent experiments and extrapolations predict a range of ca. 0.600 to 0.650 for growth of various xerophilic and halophilic eukaryotes and prokaryotes ([@ref-92], [@ref-92]). In general, cytoplasmic water activity is probably not greatly different from aqueous growth media, at 0.95 to 1 ([@ref-19], [@ref-19]). The theoretically computed transitions in relative stabilities between proteins from cancer and healthy tissues occur at much lower values of *a*~H~2~O~ (ca. 10^−6^ ; [Fig. 6B](#fig-6){ref-type="fig"}) or at values approaching 1, depending on the oxygen fugacity ([Fig. 6](#fig-6){ref-type="fig"}; [Fig. S1](#supp-2){ref-type="supplementary-material"}).

Despite the difficulties in a quantitative interpretation, theoretical predictions of stabilization of cancer-related proteins by an increase in log*f*~O~2~~ (e.g., [Figs. 6D](#fig-6){ref-type="fig"}--[6G](#fig-6){ref-type="fig"}) can be interpreted qualitatively as corresponding with an increase in effective redox potential if log*a*~H~2~O~ is held constant ([Fig. 6I](#fig-6){ref-type="fig"}). Alternatively, proteins up-expressed in cancer tissues in each of the datasets shown in [Figs. 6A](#fig-6){ref-type="fig"}--[6G](#fig-6){ref-type="fig"} can be relatively stabilized along a trajectory of increasing both log*f*~O~2~~ and log*a*~H~2~O~ at constant effective redox potential near −0.2 V ([Fig. 6I](#fig-6){ref-type="fig"}). Under this interpretation, local increases in both oxidation and hydration state are likely contributors to the proteomic transformations in colorectal cancer.

Conclusion
==========

An integrated picture of proteomic remodeling in cancer may benefit from accounting for the stoichiometric and energetic requirements of protein formation. This study has identified a strong shift toward higher average oxidation state of carbon in proteins that are more highly expressed in colorectal cancer. This pattern is identified across multiple data sets, increasing confidence in its systematic nature. In some other data sets, a systematic change can be identified indicating greater water demand for formation of human proteins in cancer compared to normal tissue.

The proteomic data can be theoretically linked to microenvironmental conditions using thermodynamic models, which give estimates of the oxidation- and hydration-potential limits for relative stability of groups of proteins. These calculations outline a path connecting the dynamic compositions of proteomes to biochemical measurements such as Eh. This approach can be used in conjunction with other datasets to characterize chemical changes in proteomes in different types of cancer and in the progression to metastasis.
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